{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:38:02Z","timestamp":1793655482973,"version":"4.5.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T00:00:00Z","timestamp":1572480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T00:00:00Z","timestamp":1572480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008398","name":"Villum Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008398","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002301","name":"Eesti Teadusagentuur","doi-asserted-by":"publisher","award":["IUT20-41"],"award-info":[{"award-number":["IUT20-41"]}],"id":[{"id":"10.13039\/501100002301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002301","name":"Eesti Teadusagentuur","doi-asserted-by":"publisher","award":["PUT784"],"award-info":[{"award-number":["PUT784"]}],"id":[{"id":"10.13039\/501100002301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002301","name":"Eesti Teadusagentuur","doi-asserted-by":"publisher","award":["IUT20-64"],"award-info":[{"award-number":["IUT20-64"]}],"id":[{"id":"10.13039\/501100002301","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Wolfram syndrome (WS) is a rare neurodegenerative disorder that is mainly characterized by diabetes mellitus, optic nerve atrophy, deafness, and progressive brainstem degeneration. Treatment with GLP-1 receptor agonists has shown a promising anti-diabetic effect in WS treatment in both animal models and in human patients. Since previous research has tended to focus on investigation of the WS first symptom, diabetes mellitus, the aim of the present study was to examine liraglutide effect on WS-associated neurodegeneration. We took 9-month-old Wfs1 knock-out (KO) animals that already had developed glucose intolerance and treated them with liraglutide for 6 months. Our research results indicate that 6-month liraglutide treatment reduced neuroinflammation and ameliorated endoplasmic reticulum (ER) stress in the inferior olive of the aged WS rat model. Liraglutide treatment also protected retinal ganglion cells from cell death and optic nerve axons from degeneration. According to this, the results of the present study provide novel insight that GLP-1 receptor agonist liraglutide has a neuroprotective effect in the WS rat model.<\/jats:p>","DOI":"10.1038\/s41598-019-52295-2","type":"journal-article","created":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T11:08:43Z","timestamp":1572520123000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["GLP-1 receptor agonist liraglutide has a neuroprotective effect on an aged rat model of Wolfram syndrome"],"prefix":"10.1038","volume":"9","author":[{"given":"Kadri","family":"Seppa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarja","family":"Toots","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riin","family":"Reimets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2863-4844","authenticated-orcid":false,"given":"Toomas","family":"Jagom\u00e4e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuuliki","family":"Koppel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maia","family":"Pallase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stine","family":"Hasselholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiken","family":"Krogsb\u00e6k Mikkelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Randel Nyengaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eero","family":"Vasar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5139-1764","authenticated-orcid":false,"given":"Anton","family":"Terasmaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Plaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,31]]},"reference":[{"key":"52295_CR1","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1136\/jmg.34.10.838","volume":"34","author":"TG Barrett","year":"1997","unstructured":"Barrett, T. G. & Bundey, S. E. Wolfram (DIDMOAD) syndrome. J. Med. Genet. 34, 838\u2013841 (1997).","journal-title":"J. Med. Genet."},{"key":"52295_CR2","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/BF00711771","volume":"18","author":"TG Barrett","year":"1995","unstructured":"Barrett, T. G., Poulton, K. & Bundey, S. DIDMOAD syndrome; further studies and muscle biochemistry. J. Inherit. Metab. Dis. 18, 218\u2013220 (1995).","journal-title":"J. Inherit. Metab. Dis."},{"key":"52295_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/2441","volume":"20","author":"H Inoue","year":"1998","unstructured":"Inoue, H. et al. A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat. Genet. 20, 143\u2013148 (1998).","journal-title":"Nat. Genet."},{"key":"52295_CR4","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00401-009-0546-8","volume":"118","author":"JB Hilson","year":"2009","unstructured":"Hilson, J. B., Merchant, S. N., Adams, J. C. & Joseph, J. T. Wolfram syndrome: a clinicopathologic correlation. Acta Neuropathol. (Berl.) 118, 415\u2013428 (2009).","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"52295_CR5","doi-asserted-by":"crossref","unstructured":"Urano, F. Wolfram Syndrome: Diagnosis, Management, and Treatment. Curr. Diab. Rep. 16, (2016).","DOI":"10.1007\/s11892-015-0702-6"},{"key":"52295_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-09392-x","volume":"7","author":"M Plaas","year":"2017","unstructured":"Plaas, M. et al. Wfs1- deficient rats develop primary symptoms of Wolfram syndrome: insulin-dependent diabetes, optic nerve atrophy and medullary degeneration. Sci. Rep. 7, 10220 (2017).","journal-title":"Sci. Rep."},{"key":"52295_CR7","unstructured":"Paul, M. S. & M Das, J. Neuroanatomy, Superior and Inferior Olivary Nucleus (Superior and Inferior Olivary Complex). In StatPearls (StatPearls Publishing, 2019)."},{"key":"52295_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-28314-z","volume":"8","author":"M Toots","year":"2018","unstructured":"Toots, M. et al. Preventive treatment with liraglutide protects against development of glucose intolerance in a rat model of Wolfram syndrome. Sci. Rep. 8, 10183 (2018).","journal-title":"Sci. Rep."},{"key":"52295_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/9239530","volume":"2016","author":"T Sedman","year":"2016","unstructured":"Sedman, T. et al. Exenatide Is an Effective Antihyperglycaemic Agent in a Mouse Model of Wolfram Syndrome 1. J. Diabetes Res. 2016, 1\u20137 (2016).","journal-title":"J. Diabetes Res."},{"key":"52295_CR10","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1007\/s00125-018-4679-y","volume":"61","author":"M Kondo","year":"2018","unstructured":"Kondo, M. et al. Activation of GLP-1 receptor signalling alleviates cellular stresses and improves beta cell function in a mouse model of Wolfram syndrome. Diabetologia 61, 2189\u20132201 (2018).","journal-title":"Diabetologia"},{"key":"52295_CR11","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.neures.2006.04.008","volume":"55","author":"T Iwai","year":"2006","unstructured":"Iwai, T., Ito, S., Tanimitsu, K., Udagawa, S. & Oka, J.-I. Glucagon-like peptide-1 inhibits LPS-induced IL-1\u03b2 production in cultured rat astrocytes. Neurosci. Res. 55, 352\u2013360 (2006).","journal-title":"Neurosci. Res."},{"key":"52295_CR12","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1111\/j.1460-9568.1995.tb00650.x","volume":"7","author":"R G\u00f6ke","year":"1995","unstructured":"G\u00f6ke, R., Larsen, P. J., Mikkelsen, J. D. & Sheikh, S. P. Distribution of GLP-1 Binding Sites in the Rat Brain: Evidence that Exendin-4 is a Ligand of Brain GLP-1 Binding Sites. Eur. J. Neurosci. 7, 2294\u20132300 (1995).","journal-title":"Eur. J. Neurosci."},{"key":"52295_CR13","doi-asserted-by":"publisher","unstructured":"Hern\u00e1ndez, C. et al. Topical administration of GLP-1 receptor agonists prevents retinal neurodegeneration in experimental diabetes. Diabetes db150443 https:\/\/doi.org\/10.2337\/db15-0443 (2015).","DOI":"10.2337\/db15-0443"},{"key":"52295_CR14","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.exer.2006.06.010","volume":"83","author":"H Yamamoto","year":"2006","unstructured":"Yamamoto, H. et al. Wolfram syndrome 1 (WFS1) protein expression in retinal ganglion cells and optic nerve glia of the cynomolgus monkey. Exp. Eye Res. 83, 1303\u20131306 (2006).","journal-title":"Exp. Eye Res."},{"key":"52295_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-42447-9","volume":"9","author":"HM Lugar","year":"2019","unstructured":"Lugar, H. M. et al. Evidence for altered neurodevelopment and neurodegeneration in Wolfram syndrome using longitudinal morphometry. Sci. Rep. 9, 6010 (2019).","journal-title":"Sci. Rep."},{"key":"52295_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2337\/diacare.6.1.67","volume":"6","author":"R Khardori","year":"1983","unstructured":"Khardori, R., Stephens, J. W., Page, O. C. & Dow, R. S. Diabetes Mellitus and Optic Atrophy in Two Siblings: A Report on a New Association and a Review of the Literature. Diabetes Care 6, 67\u201370 (1983).","journal-title":"Diabetes Care"},{"key":"52295_CR17","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s004010050635","volume":"93","author":"D Gen\u00eds","year":"1997","unstructured":"Gen\u00eds, D., D\u00e1valos, A., Molins, A. & Ferrer, I. Wolfram syndrome: a neuropathological study. Acta Neuropathol. (Berl.) 93, 426\u2013429 (1997).","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"52295_CR18","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s004010051084","volume":"98","author":"P Shannon","year":"1999","unstructured":"Shannon, P., Becker, L. & Deck, J. Evidence of widespread axonal pathology in Wolfram syndrome. Acta Neuropathol. (Berl.) 98, 304\u2013308 (1999).","journal-title":"Acta Neuropathol. (Berl.)"},{"issue":"5","key":"52295_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/foc.2007.22.5.3","volume":"22","author":"Danny Liang","year":"2007","unstructured":"Liang, D., Bhatta, S., Gerzanich, V. & Simard, J. M. Cytotoxic edema: mechanisms of pathological cell swelling. Neurosurg. Focus 1\u20139 (2007). https:\/\/doi.org\/10.3171\/foc.2007.22.5.3","journal-title":"Neurosurgical Focus"},{"key":"52295_CR20","doi-asserted-by":"publisher","first-page":"e1007196","DOI":"10.1371\/journal.pgen.1007196","volume":"14","author":"Y Sakakibara","year":"2018","unstructured":"Sakakibara, Y., Sekiya, M., Fujisaki, N., Quan, X. & Iijima, K. M. Knockdown of wfs1, a fly homolog of Wolfram syndrome 1, in the nervous system increases susceptibility to age- and stress-induced neuronal dysfunction and degeneration in Drosophila. PLOS Genet. 14, e1007196 (2018).","journal-title":"PLOS Genet."},{"key":"52295_CR21","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1111\/jnc.13169","volume":"135","author":"Y Li","year":"2015","unstructured":"Li, Y. et al. Liraglutide is neurotrophic and neuroprotective in neuronal cultures and mitigates mild traumatic brain injury in mice. J. Neurochem. 135, 1203\u20131217 (2015).","journal-title":"J. Neurochem."},{"key":"52295_CR22","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ymeth.2004.10.010","volume":"35","author":"AS Lee","year":"2005","unstructured":"Lee, A. S. The ER chaperone and signaling regulator GRP78\/BiP as a monitor of endoplasmic reticulum stress. Methods 35, 373\u2013381 (2005).","journal-title":"Methods"},{"key":"52295_CR23","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/s41593-018-0242-x","volume":"21","author":"S Hickman","year":"2018","unstructured":"Hickman, S., Izzy, S., Sen, P., Morsett, L. & El Khoury, J. Microglia in neurodegeneration. Nat. Neurosci. 21, 1359\u20131369 (2018).","journal-title":"Nat. Neurosci."},{"key":"52295_CR24","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.drudis.2016.01.013","volume":"21","author":"D Athauda","year":"2016","unstructured":"Athauda, D. & Foltynie, T. The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson\u2019s disease: mechanisms of action. Drug Discov. Today 21, 802\u2013818 (2016).","journal-title":"Drug Discov. Today"},{"key":"52295_CR25","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1042\/CS20110374","volume":"122","author":"V Darsalia","year":"2012","unstructured":"Darsalia, V. et al. Glucagon-like peptide-1 receptor activation reduces ischaemic brain damage following stroke in Type 2 diabetic rats. Clin. Sci. 122, 473\u2013483 (2012).","journal-title":"Clin. Sci."},{"key":"52295_CR26","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.neurobiolaging.2010.02.014","volume":"33","author":"S Gengler","year":"2012","unstructured":"Gengler, S., McClean, P. L., McCurtin, R., Gault, V. A. & H\u00f6lscher, C. Val(8)GLP-1 rescues synaptic plasticity and reduces dense core plaques in APP\/PS1 mice. Neurobiol. Aging 33, 265\u2013276 (2012).","journal-title":"Neurobiol. Aging"},{"key":"52295_CR27","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1073\/pnas.0806720106","volume":"106","author":"Y Li","year":"2009","unstructured":"Li, Y. et al. GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism. Proc. Natl. Acad. Sci. 106, 1285\u20131290 (2009).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"52295_CR28","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/jcbfm.2011.51","volume":"31","author":"S Teramoto","year":"2011","unstructured":"Teramoto, S. et al. Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Provides Neuroprotection in Mice Transient Focal Cerebral Ischemia. J. Cereb. Blood Flow Metab. 31, 1696\u20131705 (2011).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"52295_CR29","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1750-3639.1994.tb00838.x","volume":"4","author":"LF Eng","year":"1994","unstructured":"Eng, L. F. & Ghirnikar, R. S. GFAP and astrogliosis. Brain Pathol. Zurich Switz. 4, 229\u2013237 (1994).","journal-title":"Brain Pathol. Zurich Switz."},{"key":"52295_CR30","doi-asserted-by":"publisher","first-page":"e1000245","DOI":"10.1371\/journal.pmed.1000245","volume":"7","author":"HBvander Worp","year":"2010","unstructured":"Worp, H. Bvander et al. Can Animal Models of Disease Reliably Inform Human Studies? PLOS Med. 7, e1000245 (2010).","journal-title":"PLOS Med."},{"key":"52295_CR31","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.neuroimage.2006.01.015","volume":"31","author":"PA Yushkevich","year":"2006","unstructured":"Yushkevich, P. A. et al. User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability. NeuroImage 31, 1116\u20131128 (2006).","journal-title":"NeuroImage"},{"key":"52295_CR32","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1365-2818.1977.tb00062.x","volume":"111","author":"HJG Gundersen","year":"1977","unstructured":"Gundersen, H. J. G. Notes on the estimation of the numerical density of arbitrary profiles: the edge effect. J. Microsc. 111, 219\u2013223 (1977).","journal-title":"J. Microsc."},{"key":"52295_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2818.1986.tb02764.x","volume":"143","author":"HJ Gundersen","year":"1986","unstructured":"Gundersen, H. J. Stereology of arbitrary particles. A review of unbiased number and size estimators and the presentation of some new ones, in memory of William R. Thompson. J. Microsc. 143, 3\u201345 (1986).","journal-title":"J. Microsc."},{"key":"52295_CR34","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1046\/j.1365-2818.2001.00958.x","volume":"204","author":"KA Dorph-Petersen","year":"2001","unstructured":"Dorph-Petersen, K. A., Nyengaard, J. R. & Gundersen, H. J. Tissue shrinkage and unbiased stereological estimation of particle number and size. J. Microsc. 204, 232\u2013246 (2001).","journal-title":"J. Microsc."},{"key":"52295_CR35","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/jmi.12022","volume":"250","author":"A Rasmusson","year":"2013","unstructured":"Rasmusson, A. et al. The spatial rotator: THE SPATIAL ROTATOR. J. Microsc. 250, 88\u2013100 (2013).","journal-title":"J. Microsc."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52295-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52295-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52295-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T15:16:00Z","timestamp":1671290160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52295-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,31]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["52295"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-52295-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,31]]},"assertion":[{"value":"13 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15742"}}